Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study
Shyamala Navada, Guillermo Garcia‐Manero, Rosalie Odchimar-Reissig, Naveen Pemmaraju, Yesid Alvarado, Maro Ohanian, Rosmy John, Erin P. Demakos, Patrick S. Zbyszewski, Manoj Maniar, Richard C. Woodman, Steven Fruchtman, Lewis R. Silverman
Topics & Concepts
MedicineAzacitidineMyelodysplastic syndromesNauseaInternal medicineMyeloid leukemiaAdverse effectHypomethylating agentGastroenterologyChronic myelomonocytic leukemiaMyeloidRashRefractory (planetary science)Bone marrowGeneBiochemistryChemistryPhysicsDNA methylationAstrobiologyGene expressionAcute Myeloid Leukemia ResearchPneumocystis jirovecii pneumonia detection and treatmentHistone Deacetylase Inhibitors Research